Anaptysbio (ANAB) Revenue (2016 - 2026)
Anaptysbio (ANAB) posted Revenue of $25.6 million for Q1 2026, down 65.93% on a QoQ basis from $75.0 million in Q4 2025, and down 7.98% year-over-year from $27.8 million in Q1 2025.
Anaptysbio (ANAB) Revenue (2016 - 2026) Analysis & Trends
Anaptysbio's Revenue history runs 11 years deep, the most recent figure standing at $25.6 million for Q1 2026.
- Quarterly Revenue fell 7.98% year-over-year to $25.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $172.8 million (up 119.47% YoY) and the FY2025 annual result came in at $234.6 million, up 157.01% from the prior year.
- Revenue was $25.6 million for Q1 2026 at Anaptysbio, down from $75.0 million in the prior quarter.
- Across five years, Revenue topped out at $75.0 million in Q4 2025 and bottomed at $970000.0 in Q1 2022.
- A 5-year average of $16.7 million and a median of $9.0 million in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue plunged 93.92% — and 2024, when it surged 422.49%.
- Anaptysbio's Revenue stood at $5.0 million in 2022, then surged by 80.1% to $9.0 million in 2023, then soared by 177.62% to $25.0 million in 2024, then jumped by 200.0% to $75.0 million in 2025, then tumbled by 65.93% to $25.6 million in 2026.
- Business Quant data shows ANAB's Revenue at $25.6 million in Q1 2026, $75.0 million in Q4 2025, and $50.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - | 25.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.56 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Sep 30, 2025 | 50.00 Mn |
| Jun 30, 2025 | 22.26 Mn |
| Mar 31, 2025 | 27.77 Mn |
| Dec 31, 2024 | 25.00 Mn |
| Sep 30, 2024 | 15.00 Mn |
| Jun 30, 2024 | 10.97 Mn |
| Mar 31, 2024 | 7.18 Mn |
| Dec 31, 2023 | 9.01 Mn |
| Sep 30, 2023 | 3.32 Mn |
| Jun 30, 2023 | 3.46 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 970,000.00 |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 20.00 Mn |
| Jun 30, 2021 | 20.00 Mn |